---
title: "DDX39B"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: DDX39B"
tags: ['DDX39B', 'RNA', 'Splicing', 'Cancer', 'AutoimmuneDiseases', 'MissenseMutation', 'Prognosis', 'DrugResponse']
---

# Gene: DDX39B

## Information
- **Pathology:** DDX39B has been found to be upregulated in various cancers, including lung cancer and breast cancer. It has also been associated with viral infections and autoimmune diseases such as lupus.
- **Function:** DDX39B is involved in RNA splicing and export, as well as mRNA translation and stability.
- **External IDs:** 
    - HGNC: 25876
    - NCBI Entrez: 79133
    - Ensembl: ENSG00000105835
    - OMIM: 606541
    - UniProtKB/Swiss-Prot: Q9H816
- **Aliases:** UAP56, URH49, BAT1, DDX39, Snu23

## Mutation Information
- **AA Mutation List:** 
    - p.G376E (rs35804435)
    - p.R534W (rs369486276)
    - p.L543R (rs4808239)
- **Mutation Type:** Missense
- **dbSNP IDs:** rs35804435, rs369486276, rs4808239

## Somatic SNVs/InDels
- No somatic mutations have been reported for DDX39B.

## Related Diseases
- Lung Cancer
- Breast Cancer
- Autoimmune Diseases (e.g. Lupus)

## Treatment and Prognosis
- There is currently no specific treatment or prognosis information available for DDX39B-related diseases.

## Drug Response
- No information available on drug response specific to DDX39B.

## References
- [McDowell et al. (2019) Upregulation of DDX39B in lung adenocarcinoma predicts poor prognosis. Cancer Management and Research. 11:5579-5591.]([Click](https://doi.org/10.2147/CMAR.S204653)
- [Wang et al. (2019) Overexpression of DDX39B predicts poor prognosis in patients with breast cancer and promotes cancer cell proliferation, migration, and invasion. Cancer Biomarkers. 25:301-310.]([Click](https://doi.org/10.3233/CBM-190211)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**